7 documents found, page 1 of 1

Sort by Issue Date

Variabilidade de Apresentação do Tumor de Células Claras: Relato de Casos Clínicos

Veiga, F; Nogueira, A; Rito, M; Martins, M; Zagalo, C; Gomes, P

O cancro afeta signifcativamente a população mundial, tendo sido estimado, em 2018, que o Cancro da Cabeça e Pescoço seria o sétimo mais prevalente. As células claras podem ser resultado de diferentes processos fsiológicos e são encontradas em diversos tumores benignos e malignos. Embora sejam raras nos tumores da cabeça e pescoço, são encontradas maioritariamente nas glândulas salivares. Os tumores de células ...


A Case Report of a Sclerotic Fibroma of the Oral Mucosa

Figueiredo, L; Leite, PM; Varela, M; Veiga, F; Fernandes, A

Sclerotic fibroma, also known as storiform collagenoma, is a rare benign tumor that grows on the skin, but it can also appear, less frequently, in the oral mucosa. It can present as part of Cowden syndrome manifestation, especially when multiple lesions are encountered, but it may also appear as a solitary, sporadic lesion in healthy individuals. We describe a patient, diagnosed with Cowden syndrome, who presen...


Topical minoxidil-loaded nanotechnology strategies for alopecia

Santos, AC; Pereira-Silva, M; Guerra, C; Costa, D; Peixoto, D; Pereira, I; Pita, I; Ribeiro, A; Veiga, F

Androgenetic alopecia (AGA) is a multifactorial and age-related condition characterized by substantial hair loss affecting both men and women. Conventional treatments include the use of topical minoxidil (MNX) formulations to stimulate hair growth and restore hair condition. However, those treatments are associated with limited performance and a lack of tolerability and compliance due to the emergence of advers...


Comparison of ELISA and HPLC-MS methods for the determination of exenatide in b...

Pinho, A; Fortuna, A; Falcão, A; Santos, AC; Seiça, R; Estevens, C; Veiga, F; Ribeiro, A

The development of biotechnology-based active pharmaceutical ingredients, such as GLP-1 analogs, brought changes in type 2 diabetes treatment options. For better therapeutic efficiency, these active pharmaceutical ingredients require appropriate administration, without the development of adverse effects or toxicity. Therefore, it is required to develop several quantification methods for GLP-1 analogs products, ...



A Quem estamos ligados? Perfil de utilização do contacto móvel de uma Unidade d...

Gonçalves, AL; Veiga, F; Daniel, J; van Innis, M; Santos, S

Date: 2014   |   Origin: Saúde - CUF

Particularidades de um modelo de acompanhamento de enlutados em contexto de int...

Gonçalves, AL; Veiga, F; Daniel, J; van Innis, M; Santos, S

Date: 2014   |   Origin: Saúde - CUF

7 Results

Queried text

Refine Results

Author





















Date






Document Type




Access rights


Resource




Subject